Stock ScreenerStock IdeasFounder-Led CompaniesFounder-Led CompaniesA Bain & Co. study found that founder-led companies performed "3.1 times better" during the study period of 1999 to 2014
Stock ScreenerStock IdeasFounder-Led Companies
Ticker: AIV + 108 more
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PLD | PROLOGIS INC | $138.68B | $148.74 | $149.60 | 0.58% | Buy | 15 | 4.89% | -5.39% | 6.94% | 3.79% | |||
| MPT | MEDICAL PROPERTIES TRUST INC | $2.97B | $4.96 | $5.00 | 0.81% | Hold | 1 | 2.84% | N/A | N/A | N/A | |||
| SAM | BOSTON BEER CO INC | $1.89B | $181.89 | $229.71 | 26.29% | Hold | 7 | 1.24% | N/A | 20.89% | 12.18% | |||
| ARE | ALEXANDRIA REAL ESTATE EQUITIES INC | $9.27B | $53.17 | $50.78 | -4.50% | Hold | 9 | -3.31% | N/A | N/A | N/A | |||
| CPT | CAMDEN PROPERTY TRUST | $11.56B | $114.98 | $111.00 | -3.46% | Hold | 11 | 0.93% | -21.24% | N/A | N/A | |||
| LPSN | LIVEPERSON INC | $24.96M | $2.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -14.34% | |||
| RARE | ULTRAGENYX PHARMACEUTICAL INC | $2.40B | $24.35 | $54.80 | 125.05% | Strong Buy | 15 | 23.41% | N/A | -143.45% | 26.90% | |||
| AIV | APARTMENT INVESTMENT & MANAGEMENT CO | $414.31M | $2.88 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| W | WAYFAIR INC | $10.24B | $77.59 | $96.17 | 23.94% | Buy | 18 | 5.87% | N/A | -27.92% | 27.64% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.